Pygeum for Urinary Tract Health

Research suggests that Pygeum africanum, an extract derived from African cherry tree bark, may offer modest benefits for urinary symptoms associated with benign prostatic hyperplasia, though the overall evidence base remains limited and mixed. A 2019 systematic review and a 2013 review of phytotherapies both identified pygeum among herbal supplements with favorable effects on BPH-related lower urinary tract symptoms, and a 2007 pharmacological review found enough preclinical support to recommend a large-scale clinical trial, citing laboratory evidence of effects on prostate cell growth and bladder function. However, a 2000 meta-analysis of 44 randomized trials noted that the evidence specifically for pygeum was too poorly reported or limited to draw firm conclusions, and two broader systematic reviews from 2011 and 2023 characterized findings across herbal BPH treatments generally as mixed, with pygeum receiving less consistent attention than better-studied options like saw palmetto. Studies in this area tend to be short in duration, small in scale, and variable in methodological quality, which means that while pygeum shows some promise as a complementary approach, more rigorous and longer-term clinical research would be needed before stronger conclusions can be drawn.